
ABOUT BOEHRINGER INGELHEIM BIOPHARMACEUTICALS GMBH
BioXcellence Manufacturing - Tailored Capacities. Reliable Supply. Your Success, Our Commitment.
Boehringer Ingelheim BioXcellence™ is one of the leading biopharmaceutical contract manufacturers — a reliable partner that accompanies customers throughout the life cycle of their products. We provide E2E biopharmaceutical manufacturing based on mammalian cell culture and microbial fermentation, streamlining your product's lifecycle.
We have extensive experience with a variety of different host cells, producing a broad range of molecules in accordance with cGMP manufacturing guidelines and covering all stages of development, including aseptic filling. Our focus is on creating value for our customers through robust processes, optimal preparation for launch, and global clinical and commercial supplies of high-quality biopharmaceuticals.
With over 40 years of biotechnology experience and a team of dedicated and highly trained employees, we have helped our customers bring more than 45 biopharmaceutical medicines to the market.,.
Our network of manufacturing facilities spans the globe, from Fremont, California in the United States to Biberach in Germany, Vienna in Austria, and Shanghai in China. With more than 440 kL for mammalian cell culture and 12 kL for microbial fermentation in fully licensed multiproduct facilities we are your right partner for high-quality global supplies of biopharmaceuticals to patients.
Let’s build a future together based on our history. We have capabilities to complement your expertise and are committed to turning your biologic innovation into commercial reality.
FEATURED INDUSTRY INSIGHTS
-
Application Of Plant And Process Models
Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing.
-
Driving Operational Excellence Using Machine Learning
Explore how advanced machine learning and data analytics are revolutionizing biopharmaceutical manufacturing and driving operational excellence.
-
Setting The Standard For Plasmid DNA Production
Discover how Boehringer Ingelheim’s expertise in plasmid DNA manufacturing can propel your innovative therapies forward and transform patient care.
-
Advancements In Microbial Manufacturing Of Biopharmaceuticals
Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.
-
Microbial Manufacturing Platform For Non-Platform Proteins
Discover how CASPON® Technology can revolutionize your recombinant protein manufacturing processes and enhance efficiency.
CONTACT INFORMATION
Boehringer Ingelheim Biopharmaceuticals GmbH
Binger Strasse 173
Ingelheim, 55216
GERMANY
Contact: Dr. Barbara Esch, Head of Marketing BioXcellence
FEATURED SOLUTIONS
-
Partner with a global network of cGMP-certified mammalian cell culture manufacturing facilities to ensure scalable, high-quality biologics production and seamless global supply.
-
This content was created by Boehringer Ingelheim BioXcellence™
Among the constantly growing market of biopharmaceuticals, monoclonal antibodies derived from mammalian cell culture account for a share of approximately 50%.
-
Partner with Boehringer Ingelheim BioXcellence™ to leverage our world-class expertise and long-term commitment in advancing your product from concept to success.
-
Explore our global production network, advanced aseptic filling, in-house analytics, and the expertise that has driven 47 biopharmaceuticals to market success.
-
Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.
-
This content was created by Boehringer Ingelheim BioXcellence™
Microbial product market is a market with attractive growth – and that growth is coming from diverse molecule formats and process formats where Boehringer Ingelheim in Vienna has outstanding development and manufacturing experience. We’re proud to be pioneers in the microbial field, with a track record of success going back to the 1980s and our work on recombinant interferons. Since then, we have brought 20 microbial manufactured products to the global market: some our own, some as trusted manufacturing partner.